HLB has secured FDA for Lyrfigtu (lirafugratinib), an fibroblast growth factor receptor 2 (FGFR2)-targeted cancer drug for ...
Doctors have long known that smoking raises the risk of macular degeneration, an eye disease that slowly erodes central ...
For decades, radiologists have injected gadolinium-based contrast agents directly into patients’ joints for magnetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results